XPndAI builds custom software for femtech companies, pelvic health clinics and apps, women's intimate health platforms, endometriosis support apps, vaginismus treatment platforms, sexual pain condition apps, vaginal microbiome tracking, and women's sexual wellness brands. GDPR compliant. HIPAA (USA). Privacy-first for sensitive women's health data. Source code ownership. From $25,000. Serving USA, UK, Europe, Australia, Canada, Israel, India.
Pelvic floor dysfunction is one of the most common and most undertreated women's health conditions — affecting continence, sexual function, and quality of life. XPndAI builds pelvic floor health apps and platforms: pelvic floor exercise programme delivery (Kegel exercise programmes with audio/haptic guidance, biofeedback integration for connected pelvic floor device apps, session logging and progress tracking, programme progression based on self-reported performance), clinical assessment questionnaires (PFDI-20, PFIQ-7, PISQ-12 sexual function scale, VAS pain scale — structured intake for pelvic health physiotherapy), symptom tracking (bladder diary — frequency, urgency, leakage events; bowel diary — Bristol scale, frequency, urgency; pelvic pain tracking — location, severity, triggers, menstrual cycle correlation), connected pelvic device integration (BLE SDK for biofeedback pelvic floor devices — Elvie, Perifit, or custom device — real-time muscle activity display, exercise coaching, session data storage), telehealth physiotherapy integration (video consultation with pelvic health physiotherapist, asynchronous exercise programme prescription, home exercise programme delivery), and patient education (pelvic anatomy education, exercise technique library, condition-specific education — stress incontinence, urge incontinence, prolapse, post-partum recovery, post-menopause, pelvic pain). GDPR and HIPAA compliant — pelvic health data classified as special category (GDPR) / PHI (HIPAA). From $30,000.
Vaginismus, vulvodynia, dyspareunia, vestibulodynia, and related sexual pain conditions affect a significant proportion of women and are profoundly undertreated — often dismissed, not diagnosed, and poorly served by generic healthcare software. XPndAI builds purpose-built software for sexual pain condition clinics and platforms: structured clinical assessment (validated questionnaires — VAS pain scale, FSFI sexual function scale, FSDS sexual distress scale, Marinoff vaginismus staging, McGill Pain Questionnaire for vulvodynia), pain diary and tracking (anatomical pain mapping — location, severity, character, triggers; menstrual cycle correlation; treatment response tracking — pain score trend over treatment weeks), treatment protocol management (progressive dilation programme for vaginismus — digital programme delivery, session logging, therapist review of compliance and progress; botulinum toxin treatment scheduling and response tracking for refractory vaginismus; pelvic floor physiotherapy integration), multi-disciplinary team coordination (gynaecologist, pelvic health physiotherapist, sex therapist, pain management — shared care record, task assignment, communication within the record), and patient education and support (condition-specific education, peer support community moderation, self-help tools — all evidence-based, reviewed by the clinical team). From $35,000.
Vaginal microbiome testing is an emerging category at the intersection of women's health, consumer genomics, and sexual wellness — companies like Evvy, Juno Bio, and Vaginal Health Institute are building this market. XPndAI builds software for vaginal microbiome testing platforms: sample collection workflow (home collection kit activation, sample registration, chain of custody tracking from home to lab), lab result integration (HL7 FHIR integration with sequencing lab — 16S rRNA or whole metagenome sequencing result ingestion, parsing, and storage), patient-facing result presentation (plain-language translation of microbiome composition — Lactobacillus species, non-Lactobacillus taxa, BV-associated bacteria — with clinical context; risk stratification for BV, STI susceptibility, pregnancy outcomes, IVF success), retesting recommendation engine (based on result and clinical context — monthly for high-risk profiles, quarterly for stable Lactobacillus-dominant, post-treatment to confirm resolution), personalised intervention recommendation (probiotic selection based on specific Lactobacillus deficiency, lifestyle factors, sexual health practices — evidence-based, clinician-reviewed recommendations), and longitudinal tracking (microbiome trend across multiple tests — how has composition changed in response to interventions?). From $45,000.
Endometriosis affects approximately 200 million women worldwide and takes an average of 7–10 years to diagnose — representing a massive unmet need for better symptom tracking, clinical support, and patient empowerment tools. XPndAI builds endometriosis and chronic women's health condition management software: comprehensive symptom diary (pain — location, severity, character, cycle day; gastrointestinal symptoms — bloating, nausea, bowel habits; bladder symptoms — frequency, urgency, dysuria; fatigue severity; menstrual flow; sexual symptoms — dyspareunia, relationship impact; mood and mental health), cycle and hormone tracking (menstrual cycle length and irregularity; ovulation predictor; hormonal therapy response tracking — Prostap/Zoladex/dienogest/combined pill; surgical outcome tracking — symptom change post-laparoscopy), clinical appointment preparation (automated symptom summary for GP or gynaecologist appointment — key symptoms, medication history, cycle data — print or share directly with clinician), flare management support (symptom escalation alerts, heat therapy reminders, medication tracking, emergency contact for severe episodes), and community and peer support platform (moderated community for endometriosis patients — symptom sharing, treatment experience, provider recommendations; peer support moderated by clinical team). From $35,000.
AI tools for women's intimate health companies — built with the sensitivity, evidence-base, and clinical governance that this domain demands. XPndAI builds: AI symptom checker (conversational symptom assessment — pelvic pain, sexual symptoms, discharge characteristics, urinary symptoms — with structured output suggesting appropriate clinical pathway; does not diagnose; all AI output reviewed against clinical guidelines; disclaimer that this is not a medical diagnosis and user should consult a clinician for any health concern), AI pelvic health coach (personalised pelvic floor exercise guidance — adapts programme based on session performance data, symptom changes, menstrual cycle phase; delivered as conversational in-app coach; all coaching content reviewed by pelvic health physiotherapist), AI condition education (personalised education content based on user's condition profile — endometriosis, vaginismus, vulvodynia — plain-language, evidence-based, reviewed by clinical team), AI provider matching (based on symptom profile, geographic location, insurance, and waiting time — suggests appropriate specialist: pelvic physiotherapist, gynaecologist, sex therapist, pain management), and AI research summarisation (for clinician-facing tools — automatic summarisation of new evidence on treatment protocols, presented to clinical team for review). Privacy-preserving: no sensitive women's health data sent to third-party AI providers. From $20,000 module.
Women's intimate health data — menstrual and reproductive health, sexual function, pelvic health, microbiome, and sexual pain condition data — is among the most sensitive personal data that exists. The legal, ethical, and reputational stakes of a privacy violation are profound. XPndAI builds privacy-first architecture for women's health apps: GDPR Article 9 special category data handling (explicit consent for intimate health data processing, minimal data collection, clear retention limits, full user control including right to erasure that actually deletes), post-Dobbs architecture (USA) — following the overturning of Roe v. Wade, reproductive health data has potential legal implications in some US states; XPndAI architects platforms where reproductive data cannot be compelled from the platform (on-device processing, E2E encryption, minimal server-side storage — ensuring the platform genuinely cannot produce user reproductive data to a subpoena), CCPA sensitive personal information compliance (health information and sexual orientation data), no advertising technology embedded in the app, and privacy audit capability (users can see exactly what data is stored about them and delete it with one action — genuine deletion, not soft delete). From $20,000 as a dedicated privacy architecture engagement; included in full platform builds.
Following the Dobbs v. Jackson Women's Health Organization decision overturning Roe v. Wade, reproductive health data has potential legal implications in some US states — period tracking data, pregnancy records, and location data could theoretically be subpoenaed in states with abortion restrictions. XPndAI builds architectures for women's health apps that take this seriously: (1) On-device processing — wherever possible, sensitive reproductive health computations (cycle analysis, ovulation prediction) are performed on the user's device and the results, not the raw data, are stored in the cloud — this limits what is available on the server to be subpoenaed; (2) End-to-end encryption — sensitive reproductive health data encrypted with keys that only the user holds, meaning the platform operator cannot decrypt and produce the data even if legally compelled to do so (note: E2E encryption means the user also cannot recover data if they lose their key — there is a usability trade-off; XPndAI advises clients on the appropriate level of encryption given their specific risk profile); (3) Minimal server-side storage — the platform only stores what is necessary for the service to function; data that does not need to be stored server-side is not stored server-side; (4) Clear data deletion — deletion of user data actually deletes it (not soft delete); users can request complete account deletion and receive confirmation; (5) Privacy policy transparency — plain-language explanation of what data is stored, how it is used, what would happen in response to a law enforcement request, and how to delete data. XPndAI is a software development company; legal advice on the specific obligations of your platform in specific US states should be obtained from a privacy attorney with US healthcare and reproductive rights expertise.
Tell us your femtech company, product category, geographic market, and budget. We scope and respond within 3 business days.
XPndAI · Women's Intimate Health Software · Femtech App Development · Pelvic Health App · Endometriosis App · Sexual Pain Platform · Vaginal Microbiome · Privacy-First · GDPR / HIPAA · Source Code Ownership · From $25,000 · +91-9625368140